Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-08-19

Clinical Trial Update: Dapagliflozin on Renal Morphology and Renal Perfusion in Patients One Year After Kidney Transplantation [Phase 4]

View source ↗

Summary

Clinical trial update on the effects of dapagliflozin on renal morphology and perfusion in patients one year after kidney transplantation; Phase 4, currently re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FARXIGA (dapagliflozin)

Snippet

Sponsor: University of Erlangen-Nürnberg Medical School | Conditions: Chronic Kidney Diseases | Phase 4 | Status: RECRUITING